The Company has launched a strategic partnership with U.S. technology company Coupang, Inc. to jointly expand its Content Commerce and Retail Media Network ecosystem The partnership will leverage the Company's multi-brand portfolio of premium media content and advertising inventory across its expansive and diverse media network, including The News Lens, Business Insider Taiwan, INSIDE, Roomie, […]

Updated lexicons reinforce destination promotion as a common good and advance destination advocacy through a resonant, shared vocabulary Destinations International (DI), the world's leading association for destination organizations, today proudly marks World Tourism Lexicon Day with the release of 2025 Tourism Lexicons. This recognition reaffirms the industry's shared belief that destination promotion is a common

Locations in Manhattan, Brooklyn and Nassau County Are Among Just 1% Nationwide to Achieve Consistent “A” Grades from The Leapfrog Group NYU Langone hospitals continue to receive elite distinctions in patient safety and quality, joining just 1% of hospitals nationwide to receive 11 consecutive “A” grades from The Leapfrog Group, a national nonprofit watchdog organization

Believes that the RemainCo sale price of $2.75 per share is woefully inadequate, apparently valuing the company's casino operations and tavern business at a fraction of where it should trade, let alone be sold for. Views the RemainCo sale as an opportunistic attempt by the CEO to take advantage of company's stock price hitting a

icotec, the pioneer of implantable devices made from BlackArmor® Engineered Carbon/PEEK, today announced that the U.S. Food and Drug Administration (FDA) has cleared the CMORE® CT Systemfor use in the cervicothoracic spine. https://mma.prnewswire.com/media/2821866/CMORE_FDA_Clearance_Social_Media_Graphic__1.jpg The CMORE® (CT) System is an enhanced set of instruments and implants for posterior stabilization of the upper spine. The world's first

Proven industry leader brings focus on innovation Acosta Europe announced today that Nicole Brittain has joined the organisation as president. In this role, Brittain oversees go-to-market strategy, business operations, and innovation, reporting to Lisa Koth, Acosta Group Chief Strategy Officer and EVP, Acosta Europe. Acosta Europe is comprised of Reach and Dee Set, two of

— Revenue increased 14% vs. prior year with strong performance across all end markets — Net Income of $32.9 million reflecting robusttopline, cost optimization and manufacturing leverage — Adjusted EBITDA increased 16% vs. prior year from high demand and operational execution — Advanced innovation leadership with launch of industry's largest stack tumbler and new payment

Mile Marker has been selected by Modern Healthcare and Ad Age as a winner of the 2025 Healthcare Marketing Impact Awards. Mile Marker received the Silver Award for Data Driven Campaign in the Suppliers/Vendors/Pharmaceutical Companies category for its excellent Precise Targeting campaign for NeuroStar Advanced Therapy. The profiles of all the winners are featured in

Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, today announced the appointment of Carlos Martin as Chief Commercial Officer (CCO). Martin brings more than 20 years of leadership experience across global biopharmaceutical markets, with a proven record of building commercial organizations, launching transformative therapies, and strengthening pipeline valuation in highly innovative areas such

First Pratt & Whitney facility in the Netherlands will drive collaboration on aircraft propulsion technology research and development across industry and academia Pratt & Whitney, an RTX (NYSE:RTX) business, has formally opened its European Technology and Innovation Center (ETIC), a new facility dedicated to researching advanced propulsion technologies for enabling greater energy efficiency and performance